An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function
Heat-shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of posttranslational modifications that affect its function, including acetylation. Histone deacetylase (HDAC) inhibitors and knockdown of HDAC6 ind...
Saved in:
Published in | Molecular cell Vol. 25; no. 1; pp. 151 - 159 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
12.01.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 1097-2765 1097-4164 |
DOI | 10.1016/j.molcel.2006.12.008 |
Cover
Loading…
Abstract | Heat-shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of posttranslational modifications that affect its function, including acetylation. Histone deacetylase (HDAC) inhibitors and knockdown of HDAC6 induce Hsp90 acetylation and inhibit its activity. However, direct determination of the functional consequences of Hsp90 acetylation has awaited mapping of specific sites. We now demonstrate that Hsp90 K294 is acetylated. Mutational analysis of K294 shows that its acetylation status is a strong determinant of client protein and cochaperone binding. In yeast, Hsp90 mutants that cannot be acetylated at K294 have reduced viability and chaperone function compared to WT or to mutants that mimic constitutive acetylation. These data suggest that acetylation/deacetylation of K294 plays an important role in regulating the Hsp90 chaperone cycle. |
---|---|
AbstractList | Heat-shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of posttranslational modifications that affect its function, including acetylation. Histone deacetylase (HDAC) inhibitors and knockdown of HDAC6 induce Hsp90 acetylation and inhibit its activity. However, direct determination of the functional consequences of Hsp90 acetylation has awaited mapping of specific sites. We now demonstrate that Hsp90 K294 is acetylated. Mutational analysis of K294 shows that its acetylation status is a strong determinant of client protein and cochaperone binding. In yeast, Hsp90 mutants that cannot be acetylated at K294 have reduced viability and chaperone function compared to WT or to mutants that mimic constitutive acetylation. These data suggest that acetylation/deacetylation of K294 plays an important role in regulating the Hsp90 chaperone cycle. Heat shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of post-translational modifications which affect its function, including acetylation. Histone deacetylase (HDAC) inhibitors and knock-down of HDAC6 induce Hsp90 acetylation and inhibit its activity. However, direct determination of the functional consequences of Hsp90 acetylation has awaited mapping of specific sites. We now demonstrate that Hsp90 K294 is acetylated. Mutational analysis of K294 shows that its acetylation status is a strong determinant of client protein and cochaperone binding. In yeast, Hsp90 mutants that cannot be acetylated at K294 have reduced viability and chaperone function compared to wild type or to mutants that mimic constitutive acetylation. These data suggest that acetylation/deacetylation of K294 plays an important role in regulating the Hsp90 chaperone cycle. Heat-shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of posttranslational modifications that affect its function, including acetylation. Histone deacetylase (HDAC) inhibitors and knockdown of HDAC6 induce Hsp90 acetylation and inhibit its activity. However, direct determination of the functional consequences of Hsp90 acetylation has awaited mapping of specific sites. We now demonstrate that Hsp90 K294 is acetylated. Mutational analysis of K294 shows that its acetylation status is a strong determinant of client protein and cochaperone binding. In yeast, Hsp90 mutants that cannot be acetylated at K294 have reduced viability and chaperone function compared to WT or to mutants that mimic constitutive acetylation. These data suggest that acetylation/deacetylation of K294 plays an important role in regulating the Hsp90 chaperone cycle.Heat-shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of posttranslational modifications that affect its function, including acetylation. Histone deacetylase (HDAC) inhibitors and knockdown of HDAC6 induce Hsp90 acetylation and inhibit its activity. However, direct determination of the functional consequences of Hsp90 acetylation has awaited mapping of specific sites. We now demonstrate that Hsp90 K294 is acetylated. Mutational analysis of K294 shows that its acetylation status is a strong determinant of client protein and cochaperone binding. In yeast, Hsp90 mutants that cannot be acetylated at K294 have reduced viability and chaperone function compared to WT or to mutants that mimic constitutive acetylation. These data suggest that acetylation/deacetylation of K294 plays an important role in regulating the Hsp90 chaperone cycle. |
Author | Robzyk, Kenneth Beebe, Kristin Tsutsumi, Shinji Wang, Dongxia Felts, Sara Karnitz, Larry Neckers, Len Marcu, Monica G. Scroggins, Bradley T. Cotter, Robert J. Rosen, Neal Toft, David |
Author_xml | – sequence: 1 givenname: Bradley T. surname: Scroggins fullname: Scroggins, Bradley T. organization: Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA – sequence: 2 givenname: Kenneth surname: Robzyk fullname: Robzyk, Kenneth organization: Department of Medicine and Program in Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA – sequence: 3 givenname: Dongxia surname: Wang fullname: Wang, Dongxia organization: Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA – sequence: 4 givenname: Monica G. surname: Marcu fullname: Marcu, Monica G. organization: Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA – sequence: 5 givenname: Shinji surname: Tsutsumi fullname: Tsutsumi, Shinji organization: Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA – sequence: 6 givenname: Kristin surname: Beebe fullname: Beebe, Kristin organization: Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA – sequence: 7 givenname: Robert J. surname: Cotter fullname: Cotter, Robert J. organization: Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA – sequence: 8 givenname: Sara surname: Felts fullname: Felts, Sara organization: Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA – sequence: 9 givenname: David surname: Toft fullname: Toft, David organization: Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA – sequence: 10 givenname: Larry surname: Karnitz fullname: Karnitz, Larry organization: Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA – sequence: 11 givenname: Neal surname: Rosen fullname: Rosen, Neal organization: Department of Medicine and Program in Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA – sequence: 12 givenname: Len surname: Neckers fullname: Neckers, Len email: len@helix.nih.gov organization: Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17218278$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUctuGyEURVGqvJo_iCpW3XkKDMMwXVSynKaplDZSmq4RZi4x1gy4wETK3xfXTl-LdgXinhf3nKJDHzwgdEFJRQkVb9bVGAYDQ8UIERVlFSHyAJ1Q0rUzTgU_3N9ZK5pjdJrSmhDKG9kdoWPaMipZK0_Q57nHcwP5adDZBY-_uAzYeZxXgD-5vh8AX4ZRl5dg8XXadATfwcNU0JDwYqU3EEssfDV5s-W_RC-sHhKc788z9PXq_f3ienZz--HjYn4zMw1r88zWWvdtbWkjuOwNl5LRbskJLbEIk3YpG9kIwxnRtiZWC9MzzmpRd61lsIT6DL3b6W6m5Qi9AZ-jHtQmulHHJxW0U39OvFuph_CoqKy7TvIi8HovEMO3CVJWo0tlm4P2EKakhCzmNe8K8NXvTj8tnldYAHwHMDGkFMH-ghC1bUqt1a4ptW1KUaZKU4X29i-acflHByWvG_5H3n8fyo4fHUSVjANvoHcRTFZ9cP8W-A6eJLDk |
CitedBy_id | crossref_primary_10_1016_j_mito_2009_08_009 crossref_primary_10_1016_j_mito_2009_08_007 crossref_primary_10_1371_journal_pone_0028228 crossref_primary_10_1038_srep32257 crossref_primary_10_1128_AAC_02286_13 crossref_primary_10_1586_epr_11_2 crossref_primary_10_1093_jmcb_mjr025 crossref_primary_10_1111_cmi_12266 crossref_primary_10_1016_j_bbamcr_2011_10_013 crossref_primary_10_1016_j_jmb_2022_167506 crossref_primary_10_1016_j_neuron_2016_03_005 crossref_primary_10_1021_acs_jmedchem_8b00151 crossref_primary_10_3389_fonc_2020_01177 crossref_primary_10_1002_ijc_23885 crossref_primary_10_1111_jnc_13238 crossref_primary_10_1517_14728222_2013_740013 crossref_primary_10_1128_JVI_02110_17 crossref_primary_10_1161_CIRCRESAHA_112_268706 crossref_primary_10_18632_oncotarget_1099 crossref_primary_10_1016_j_gene_2015_06_018 crossref_primary_10_1016_j_pneurobio_2010_10_006 crossref_primary_10_1016_j_canlet_2017_01_033 crossref_primary_10_1021_acs_jmedchem_2c01433 crossref_primary_10_3389_fmicb_2022_911322 crossref_primary_10_1080_14728222_2021_1860016 crossref_primary_10_1016_j_phymed_2020_153187 crossref_primary_10_1016_j_pneurobio_2010_05_002 crossref_primary_10_1038_nsmb0109_2 crossref_primary_10_1016_j_jhepr_2021_100316 crossref_primary_10_1038_nsmb_1682 crossref_primary_10_1016_j_bbamcr_2011_09_003 crossref_primary_10_1021_acs_chemrev_7b00181 crossref_primary_10_1152_ajprenal_00186_2017 crossref_primary_10_1186_1471_2407_11_520 crossref_primary_10_1515_hsz_2018_0251 crossref_primary_10_3390_ijms131215706 crossref_primary_10_7314_APJCP_2012_13_7_3471 crossref_primary_10_3390_pathogens13010033 crossref_primary_10_1021_acs_jmedchem_9b00924 crossref_primary_10_1016_j_celrep_2012_08_035 crossref_primary_10_1016_j_ejmech_2021_113173 crossref_primary_10_1007_s12192_014_0533_4 crossref_primary_10_1182_blood_2008_03_143644 crossref_primary_10_1016_j_cclet_2017_01_003 crossref_primary_10_1097_JTO_0b013e3181bc9419 crossref_primary_10_1091_mbc_e10_03_0203 crossref_primary_10_4331_wjbc_v1_i5_55 crossref_primary_10_1016_j_bbamcr_2018_03_008 crossref_primary_10_1016_j_bbadis_2011_11_011 crossref_primary_10_1126_science_1175371 crossref_primary_10_1016_j_drup_2008_12_002 crossref_primary_10_1074_jbc_M113_520734 crossref_primary_10_1517_14728221003621278 crossref_primary_10_1038_nrc2887 crossref_primary_10_1002_jcp_22856 crossref_primary_10_1523_JNEUROSCI_5634_11_2012 crossref_primary_10_1158_1078_0432_CCR_08_0376 crossref_primary_10_1016_j_trsl_2014_04_006 crossref_primary_10_3390_ijms20204976 crossref_primary_10_1369_0022155413506582 crossref_primary_10_1128_MCB_05155_11 crossref_primary_10_2217_imt_2016_0071 crossref_primary_10_1371_journal_pone_0029085 crossref_primary_10_1007_s10571_020_00994_0 crossref_primary_10_1517_17460441_2011_563296 crossref_primary_10_1016_j_molcel_2013_12_007 crossref_primary_10_1016_j_molmed_2024_04_018 crossref_primary_10_1016_j_canlet_2014_05_014 crossref_primary_10_1016_j_ijbiomac_2023_123219 crossref_primary_10_1007_s00018_009_0233_x crossref_primary_10_1038_s41467_023_38230_0 crossref_primary_10_1038_cdd_2013_47 crossref_primary_10_3389_fonc_2022_868866 crossref_primary_10_1038_onc_2014_453 crossref_primary_10_3390_ijms22115950 crossref_primary_10_1016_j_celrep_2019_09_023 crossref_primary_10_1021_acs_jpcb_2c03464 crossref_primary_10_1517_17460441_2_10_1403 crossref_primary_10_1016_j_bbamcr_2014_11_026 crossref_primary_10_1080_17476348_2016_1206819 crossref_primary_10_1152_ajplung_00419_2012 crossref_primary_10_1111_bph_15231 crossref_primary_10_4155_ppa_12_21 crossref_primary_10_1111_cas_13748 crossref_primary_10_1038_srep31086 crossref_primary_10_1186_s10020_021_00375_3 crossref_primary_10_3390_molecules29071573 crossref_primary_10_1074_jbc_RA119_010524 crossref_primary_10_1073_pnas_1119181109 crossref_primary_10_1371_journal_pgen_1011338 crossref_primary_10_1073_pnas_0907935106 crossref_primary_10_1158_1541_7786_MCR_07_0324 crossref_primary_10_3390_cancers14040972 crossref_primary_10_1016_j_tibs_2013_02_003 crossref_primary_10_1101_cshperspect_a034017 crossref_primary_10_1016_j_neurobiolaging_2020_02_006 crossref_primary_10_1155_2011_918707 crossref_primary_10_3390_molecules20058000 crossref_primary_10_1080_14728222_2020_1762568 crossref_primary_10_1021_jm401801t crossref_primary_10_1128_MCB_00393_07 crossref_primary_10_4155_fmc_2016_0073 crossref_primary_10_1093_hmg_ddw255 crossref_primary_10_1017_S0031182014000055 crossref_primary_10_1111_j_1600_0854_2012_01347_x crossref_primary_10_1593_neo_91422 crossref_primary_10_1016_j_bbamcr_2019_118615 crossref_primary_10_1016_j_arr_2009_06_002 crossref_primary_10_1021_cb9000316 crossref_primary_10_1002_bip_21292 crossref_primary_10_1007_s12192_010_0200_3 crossref_primary_10_1007_s11064_008_9622_z crossref_primary_10_1016_j_jmb_2009_11_017 crossref_primary_10_1038_s41467_020_15048_8 crossref_primary_10_1016_j_bmc_2016_10_006 crossref_primary_10_1074_jbc_M110_152777 crossref_primary_10_1002_med_21774 crossref_primary_10_1016_j_bbapap_2016_06_007 crossref_primary_10_1021_pr200313x crossref_primary_10_1093_hmg_dds125 crossref_primary_10_1016_j_mib_2013_03_005 crossref_primary_10_1002_jcb_21640 crossref_primary_10_1042_BJ20071640 crossref_primary_10_14789_pjmj_56_257 crossref_primary_10_1016_j_leukres_2008_02_018 crossref_primary_10_3892_mmr_2019_10745 crossref_primary_10_3892_or_2016_5309 crossref_primary_10_1152_ajplung_00180_2015 crossref_primary_10_1038_s41598_018_25329_4 crossref_primary_10_1074_jbc_M114_549915 crossref_primary_10_1155_2015_132635 crossref_primary_10_11131_2014_101086 crossref_primary_10_1158_1078_0432_CCR_12_0055 crossref_primary_10_3390_antiox12040792 crossref_primary_10_2174_1381612825666190319114641 crossref_primary_10_2217_epi_11_67 crossref_primary_10_1016_j_molcel_2015_02_022 crossref_primary_10_1038_cdd_2011_71 crossref_primary_10_3390_biom5031697 crossref_primary_10_3389_fmicb_2015_00096 crossref_primary_10_1091_mbc_e07_05_0467 crossref_primary_10_1038_srep33179 crossref_primary_10_1007_s12177_011_9073_7 crossref_primary_10_1016_j_jprot_2018_06_019 crossref_primary_10_1016_j_tibs_2009_01_006 crossref_primary_10_1158_0008_5472_CAN_08_4004 crossref_primary_10_1021_acs_jcim_7b00638 crossref_primary_10_1016_j_biopsych_2014_07_036 crossref_primary_10_1371_journal_pone_0142573 crossref_primary_10_3389_fphar_2017_00997 crossref_primary_10_18632_oncotarget_19019 crossref_primary_10_1080_01480545_2018_1458237 crossref_primary_10_1042_BCJ20160005 crossref_primary_10_3390_jpm11121373 crossref_primary_10_1016_j_metabol_2012_03_019 crossref_primary_10_1523_JNEUROSCI_0016_12_2012 crossref_primary_10_1016_j_molcel_2010_01_028 crossref_primary_10_3390_biomedicines8020022 crossref_primary_10_1021_pr500585p crossref_primary_10_18632_oncotarget_5167 crossref_primary_10_1016_j_jbc_2024_107342 crossref_primary_10_1196_annals_1391_012 crossref_primary_10_3892_ol_2021_12941 crossref_primary_10_1016_j_molbiopara_2008_12_011 crossref_primary_10_1371_journal_pone_0049322 crossref_primary_10_1002_bies_201600224 crossref_primary_10_1155_2011_970382 crossref_primary_10_1016_j_jbc_2024_107907 crossref_primary_10_1038_s41388_023_02641_6 crossref_primary_10_1039_c3np70012g crossref_primary_10_4155_fmc_13_88 crossref_primary_10_1017_S0031182013002072 crossref_primary_10_3390_ph4111400 crossref_primary_10_1002_1878_0261_12054 crossref_primary_10_18632_oncotarget_27217 crossref_primary_10_4062_biomolther_2023_104 crossref_primary_10_1038_sj_embor_7400977 crossref_primary_10_1016_j_biopha_2023_114773 crossref_primary_10_1002_arch_22079 crossref_primary_10_1158_0008_5472_CAN_08_0188 crossref_primary_10_2217_epi_09_47 crossref_primary_10_1016_j_tips_2014_08_001 crossref_primary_10_1038_sj_onc_1210610 crossref_primary_10_1172_JCI42869 crossref_primary_10_1038_sj_onc_1210614 crossref_primary_10_1128_MMBR_00040_15 crossref_primary_10_1016_j_bbamcr_2011_07_018 crossref_primary_10_1080_14789450_2017_1264877 crossref_primary_10_17352_gbmg_000003 crossref_primary_10_1111_j_1582_4934_2008_00571_x crossref_primary_10_3390_genes12101470 crossref_primary_10_1042_BJ20110855 crossref_primary_10_1371_journal_pone_0106224 crossref_primary_10_1016_j_bbrc_2022_06_057 crossref_primary_10_1371_journal_pone_0030846 crossref_primary_10_2174_1570180819666220530145951 crossref_primary_10_1016_j_ddstr_2008_02_005 crossref_primary_10_1038_cddis_2010_4 crossref_primary_10_1097_NEN_0000000000000136 crossref_primary_10_1152_ajpcell_00167_2010 crossref_primary_10_1073_pnas_1221046110 crossref_primary_10_3390_ijms22179366 crossref_primary_10_1016_j_biochi_2007_06_009 crossref_primary_10_1371_journal_pone_0174107 crossref_primary_10_1016_j_jmb_2009_06_067 crossref_primary_10_1074_jbc_M112_404707 crossref_primary_10_3390_biomedicines11010088 crossref_primary_10_2337_db11_0313 crossref_primary_10_1021_tx400001x crossref_primary_10_1586_era_10_62 crossref_primary_10_1021_acs_jctc_0c00280 crossref_primary_10_1074_jbc_M111_317594 crossref_primary_10_1016_j_molcel_2008_07_002 crossref_primary_10_1038_s12276_024_01160_y crossref_primary_10_1158_0008_5472_CAN_08_0644 crossref_primary_10_1016_j_jns_2011_02_017 crossref_primary_10_1007_s13402_022_00704_6 crossref_primary_10_1016_j_bmc_2012_03_043 crossref_primary_10_1096_fj_11_193706 crossref_primary_10_18632_oncotarget_7134 crossref_primary_10_1038_s41467_024_53178_5 crossref_primary_10_1128_MCB_00265_08 crossref_primary_10_1016_j_biomaterials_2017_07_002 crossref_primary_10_1021_acs_jcim_0c00380 crossref_primary_10_3390_molecules28041771 crossref_primary_10_1016_j_pharmthera_2024_108729 crossref_primary_10_1111_febs_12147 crossref_primary_10_4062_biomolther_2019_051 crossref_primary_10_1017_S0033583510000314 crossref_primary_10_1007_s12192_020_01161_6 crossref_primary_10_1016_j_jmb_2020_06_015 crossref_primary_10_1074_jbc_REV120_011833 crossref_primary_10_1182_blood_2019895326 crossref_primary_10_1016_j_cbpa_2013_04_020 crossref_primary_10_1016_j_cellsig_2008_12_004 crossref_primary_10_1155_2011_146493 crossref_primary_10_1038_s41467_019_10463_y crossref_primary_10_1017_S0031182013002151 crossref_primary_10_1084_jem_20111117 crossref_primary_10_3892_ol_2013_1166 crossref_primary_10_1021_acs_jmedchem_1c01897 crossref_primary_10_1016_j_molcel_2011_12_031 crossref_primary_10_1042_BJ20130963 crossref_primary_10_3109_1040841X_2014_947239 crossref_primary_10_1182_blood_2007_10_116376 crossref_primary_10_1038_nrm2918 crossref_primary_10_1128_jvi_00375_23 crossref_primary_10_1515_hsz_2017_0172 crossref_primary_10_1038_msb_2012_4 crossref_primary_10_1073_pnas_1801118115 crossref_primary_10_1186_s12929_024_01101_x crossref_primary_10_1038_nrmicro2875 crossref_primary_10_1186_s13024_016_0109_0 crossref_primary_10_1093_cid_civ725 crossref_primary_10_1371_journal_pone_0102296 crossref_primary_10_1038_s41467_020_19317_4 crossref_primary_10_1096_fj_201801680R crossref_primary_10_1038_embor_2009_153 crossref_primary_10_1021_bi400638s crossref_primary_10_7554_eLife_102666 crossref_primary_10_1016_j_jhep_2021_02_028 crossref_primary_10_1016_j_bbagrm_2013_12_006 crossref_primary_10_3390_ijms20184423 crossref_primary_10_1074_mcp_RA117_000530 crossref_primary_10_1016_j_febslet_2007_05_040 crossref_primary_10_3390_ph5080779 crossref_primary_10_1074_jbc_R800007200 crossref_primary_10_1002_fsn3_1439 crossref_primary_10_4155_fmc_14_112 crossref_primary_10_1038_nrm_2017_20 crossref_primary_10_1016_j_drudis_2012_03_009 crossref_primary_10_1038_bjc_2012_576 crossref_primary_10_1016_j_freeradbiomed_2014_08_012 crossref_primary_10_1016_S1872_2040_17_61071_5 crossref_primary_10_1016_j_bbamcr_2011_07_020 crossref_primary_10_3389_fcell_2020_00425 crossref_primary_10_1016_j_celrep_2015_10_013 crossref_primary_10_6064_2012_606104 crossref_primary_10_1111_ajt_13106 crossref_primary_10_1016_j_chom_2008_10_011 crossref_primary_10_1007_s13148_011_0025_7 crossref_primary_10_1016_j_bcp_2010_01_031 crossref_primary_10_1038_s41580_023_00640_9 crossref_primary_10_1074_jbc_M808999200 crossref_primary_10_1210_me_2008_0089 crossref_primary_10_3389_fmolb_2022_1030534 crossref_primary_10_1152_ajpcell_00449_2007 crossref_primary_10_1016_j_bcp_2015_11_005 crossref_primary_10_1016_j_biocel_2008_08_027 crossref_primary_10_1016_j_jprot_2011_12_028 crossref_primary_10_1165_rcmb_2024_0159OC crossref_primary_10_1210_en_2015_2055 crossref_primary_10_1007_s00018_017_2539_4 crossref_primary_10_1128_JVI_01671_13 crossref_primary_10_1161_ATVBAHA_112_256008 crossref_primary_10_1016_j_canlet_2008_12_026 crossref_primary_10_1097_CAD_0b013e328337f373 crossref_primary_10_1016_j_neuint_2021_105141 crossref_primary_10_3389_fendo_2019_00487 crossref_primary_10_1038_nrm2346 crossref_primary_10_1111_j_1463_1326_2010_01282_x crossref_primary_10_1074_mcp_M112_024497 crossref_primary_10_1016_j_molcel_2011_02_028 crossref_primary_10_1080_1062936X_2023_2244419 crossref_primary_10_1093_neuonc_noad252 crossref_primary_10_1038_s41419_018_0688_5 crossref_primary_10_1016_j_toxlet_2019_11_022 crossref_primary_10_1016_j_jff_2015_03_018 crossref_primary_10_2174_2212796814666200309113100 crossref_primary_10_1016_j_bbagrm_2013_02_010 crossref_primary_10_1073_pnas_0908908106 crossref_primary_10_1038_nchembio_275 |
Cites_doi | 10.1016/j.molcel.2005.04.021 10.1016/S0021-9258(19)36795-X 10.1016/S0378-1119(02)01102-2 10.1016/j.bbrc.2005.09.025 10.1074/jbc.272.42.26179 10.1038/nature04716 10.1091/mbc.9.11.3071 10.1074/jbc.M105562200 10.1074/jbc.M508687200 10.1158/1078-0432.CCR-05-0344 10.1073/pnas.220430297 10.1073/pnas.170276797 10.1074/jbc.C500186200 10.1016/j.str.2004.12.018 10.1038/348166a0 10.1093/genetics/122.1.19 10.1074/jbc.M212574200 10.1093/jnci/94.7.504 10.1038/sj.emboj.7600060 10.1074/jbc.270.48.28654 10.1074/jbc.M506997200 10.1210/me.2005-0531 10.1073/pnas.202365899 10.1073/pnas.90.15.7074 10.1128/MCB.15.7.3917 10.1021/bi048736m 10.1016/0076-6879(90)85024-I 10.1128/MCB.16.10.5276 10.1073/pnas.91.18.8324 10.1021/bi983027s 10.1074/jbc.M204733200 10.1038/sj.emboj.7600930 10.1002/med.20052 |
ContentType | Journal Article |
Copyright | 2007 Elsevier Inc. |
Copyright_xml | – notice: 2007 Elsevier Inc. |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.molcel.2006.12.008 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1097-4164 |
EndPage | 159 |
ExternalDocumentID | PMC1839984 17218278 10_1016_j_molcel_2006_12_008 S1097276506008446 |
Genre | Journal Article Research Support, N.I.H., Intramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: Z01 SC010074-10 – fundername: Intramural NIH HHS |
GroupedDBID | --- --K -DZ -~X .55 .GJ 0R~ 123 1~5 29M 2WC 3O- 4.4 457 4G. 53G 5RE 5VS 62- 6I. 7-5 AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKRW AAKUH AALRI AAQFI AAQXK AAUCE AAVLU AAXJY AAXUO ABJNI ABMAC ABMWF ABVKL ACGFO ACGFS ACNCT ADBBV ADEZE ADJPV ADMUD AEFWE AENEX AEXQZ AFFNX AFTJW AGHFR AGKMS AHPSJ AITUG ALKID ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BAWUL CS3 DIK DU5 E3Z EBS EJD F5P FCP FDB FEDTE FGOYB FIRID HH5 HVGLF HZ~ IH2 IHE IXB J1W JIG KQ8 L7B M3Z M41 N9A NCXOZ O-L O9- OK1 OZT P2P R2- RCE RIG ROL RPZ SDG SES SSZ TR2 UHS WQ6 X7M ZA5 ZGI ZXP AAHBH AAMRU AAYWO AAYXX ABDGV ABWVN ACRPL ACVFH ADCNI ADNMO ADVLN AEUPX AFPUW AGCQF AGQPQ AIGII AKAPO AKBMS AKRWK AKYEP APXCP CITATION 0SF CGR CUY CVF ECM EIF NPM 7X8 5PM EFKBS |
ID | FETCH-LOGICAL-c527t-f3aad73f15648dc488219b401218028fb85856c420af30fa6cd24236397f2ebe3 |
IEDL.DBID | IXB |
ISSN | 1097-2765 |
IngestDate | Thu Aug 21 18:20:23 EDT 2025 Fri Jul 11 01:39:16 EDT 2025 Sat Sep 28 07:57:35 EDT 2024 Tue Jul 01 03:40:35 EDT 2025 Thu Apr 24 23:06:14 EDT 2025 Fri Feb 23 02:19:46 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | PROTEINS |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 https://www.elsevier.com/tdm/userlicense/1.0 https://www.elsevier.com/open-access/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c527t-f3aad73f15648dc488219b401218028fb85856c420af30fa6cd24236397f2ebe3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 To whom correspondence should be addressed at: Urologic Oncology Branch, National Cancer Institute, 9000 Rockville Pike, Bldg. 10/CRC, 1-5940, Bethesda, MD 20892-1107; telephone: 301-496-5899; fax: 301-402-0922; e-mail: len@helix.nih.gov current address: National Center of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1097276506008446 |
PMID | 17218278 |
PQID | 68420349 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1839984 proquest_miscellaneous_68420349 pubmed_primary_17218278 crossref_primary_10_1016_j_molcel_2006_12_008 crossref_citationtrail_10_1016_j_molcel_2006_12_008 elsevier_sciencedirect_doi_10_1016_j_molcel_2006_12_008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-01-12 |
PublicationDateYYYYMMDD | 2007-01-12 |
PublicationDate_xml | – month: 01 year: 2007 text: 2007-01-12 day: 12 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Molecular cell |
PublicationTitleAlternate | Mol Cell |
PublicationYear | 2007 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Picard, Khursheed, Garabedian, Fortin, Lindquist, Yamamoto (bib25) 1990; 348 Sikorski, Hieter (bib30) 1989; 122 Murphy, Morishima, Kovacs, Yao, Pratt (bib20) 2005; 280 Hartson, Thulasiraman, Huang, Whitesell, Matts (bib10) 1999; 38 Piper, Panaretou, Millson, Trumana, Mollapour, Pearl, Prodromou (bib26) 2003; 302 Xu, Lindquist (bib35) 1993; 90 Blagosklonny, Robey, Sackett, Du, Traganos, Darzynkiewicz, Fojo, Bates (bib6) 2002; 1 Nimmanapalli, Fuino, Bali, Gasparetto, Glozak, Tao, Moscinski, Smith, Wu, Jove (bib23) 2003; 63 Furumai, Matsuyama, Kobashi, Lee, Nishiyama, Nakajima, Tanaka, Komatsu, Nishino, Yoshida, Horinouchi (bib9) 2002; 62 Blagg, Kerr (bib5) 2006; 26 MacLean, Llordella, Bot, Picard (bib17) 2005; 337 Whitesell, Mimnaugh, De Costa, Myers, Neckers (bib34) 1994; 91 Ali, Roe, Vaughan, Meyer, Panaretou, Piper, Prodromou, Pearl (bib1) 2006; 440 Huai, Wang, Liu, Kim, Toft, Ke (bib11) 2005; 13 Sartor, McLellan, Chiueh (bib28) 1992; 267 Louvion, Abbas-Terki, Picard (bib16) 1998; 9 Kovacs, Murphy, Gaillard, Zhao, Wu, Nicchitta, Yoshida, Toft, Pratt, Yao (bib15) 2005; 18 Chadli, Bouhouche, Sullivan, Stensgard, McMahon, Catelli, Toft (bib7) 2000; 97 Nathan, Lindquist (bib21) 1995; 15 Xu, Marcu, Yuan, Mimnaugh, Patterson, Neckers (bib36) 2002; 99 Ogiso, Kagi, Matsumoto, Nishimoto, Arai, Shirouzu, Mimura, Fujii-Kuriyama, Yokoyama (bib24) 2004; 43 Meyer, Prodromou, Liao, Hu, Mark Roe, Vaughan, Vlasic, Panaretou, Piper, Pearl (bib18) 2004; 23 Kim, Woo, Chong, Homenko, Kraus (bib13) 2006; 20 Wang, Tsay, Tan, Lo, Lee (bib33) 2003; 278 Tzahar, Waterman, Chen, Levkowitz, Karunagaran, Lavi, Ratzkin, Yarden (bib31) 1996; 16 Wandinger, Suhre, Wegele, Buchner (bib32) 2006; 25 Zhao, Gilmore, Leone, Coffey, Weber, Lee (bib38) 2001; 276 Bali, Pranpat, Bradner, Balasis, Fiskus, Guo, Rocha, Kumaraswamy, Boyapalle, Atadja (bib3) 2005; 280 Sato, Fujita, Tsuruo (bib29) 2000; 97 Nemoto, Sato, Iwanari, Yamashita, Takagi (bib22) 1997; 272 Bali, Pranpat, Swaby, Fiskus, Yamaguchi, Balasis, Rocha, Wang, Richon, Bhalla (bib4) 2005; 11 Isaacs, Jung, Mimnaugh, Martinez, Cuttitta, Neckers (bib12) 2002; 277 Mimnaugh, Worland, Whitesell, Neckers (bib19) 1995; 270 Arlander, Felts, Wagner, Stensgard, Toft, Karnitz (bib2) 2006; 281 Rose, Broach (bib27) 1990; 185 Yu, Guo, Marcu, Neckers, Nguyen, Chen, Schrump (bib37) 2002; 94 Bali (10.1016/j.molcel.2006.12.008_bib4) 2005; 11 Sato (10.1016/j.molcel.2006.12.008_bib29) 2000; 97 Bali (10.1016/j.molcel.2006.12.008_bib3) 2005; 280 Isaacs (10.1016/j.molcel.2006.12.008_bib12) 2002; 277 Chadli (10.1016/j.molcel.2006.12.008_bib7) 2000; 97 Ali (10.1016/j.molcel.2006.12.008_bib1) 2006; 440 Wang (10.1016/j.molcel.2006.12.008_bib33) 2003; 278 Nemoto (10.1016/j.molcel.2006.12.008_bib22) 1997; 272 Tzahar (10.1016/j.molcel.2006.12.008_bib31) 1996; 16 Piper (10.1016/j.molcel.2006.12.008_bib26) 2003; 302 Blagosklonny (10.1016/j.molcel.2006.12.008_bib6) 2002; 1 Furumai (10.1016/j.molcel.2006.12.008_bib9) 2002; 62 Ogiso (10.1016/j.molcel.2006.12.008_bib24) 2004; 43 Xu (10.1016/j.molcel.2006.12.008_bib35) 1993; 90 Wandinger (10.1016/j.molcel.2006.12.008_bib32) 2006; 25 Xu (10.1016/j.molcel.2006.12.008_bib36) 2002; 99 Sartor (10.1016/j.molcel.2006.12.008_bib28) 1992; 267 Blagg (10.1016/j.molcel.2006.12.008_bib5) 2006; 26 Meyer (10.1016/j.molcel.2006.12.008_bib18) 2004; 23 Zhao (10.1016/j.molcel.2006.12.008_bib38) 2001; 276 Nimmanapalli (10.1016/j.molcel.2006.12.008_bib23) 2003; 63 Picard (10.1016/j.molcel.2006.12.008_bib25) 1990; 348 Kovacs (10.1016/j.molcel.2006.12.008_bib15) 2005; 18 Rose (10.1016/j.molcel.2006.12.008_bib27) 1990; 185 Mimnaugh (10.1016/j.molcel.2006.12.008_bib19) 1995; 270 Sikorski (10.1016/j.molcel.2006.12.008_bib30) 1989; 122 MacLean (10.1016/j.molcel.2006.12.008_bib17) 2005; 337 Huai (10.1016/j.molcel.2006.12.008_bib11) 2005; 13 Yu (10.1016/j.molcel.2006.12.008_bib37) 2002; 94 Louvion (10.1016/j.molcel.2006.12.008_bib16) 1998; 9 Arlander (10.1016/j.molcel.2006.12.008_bib2) 2006; 281 Hartson (10.1016/j.molcel.2006.12.008_bib10) 1999; 38 Whitesell (10.1016/j.molcel.2006.12.008_bib34) 1994; 91 Kim (10.1016/j.molcel.2006.12.008_bib13) 2006; 20 Nathan (10.1016/j.molcel.2006.12.008_bib21) 1995; 15 Murphy (10.1016/j.molcel.2006.12.008_bib20) 2005; 280 12052835 - J Biol Chem. 2002 Aug 16;277(33):29936-44 12481415 - Mol Cancer Ther. 2002 Sep;1(11):937-41 10995457 - Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10832-7 11438552 - J Biol Chem. 2001 Aug 31;276(35):32822-7 7499384 - J Biol Chem. 1995 Dec 1;270(48):28654-9 11050175 - Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12524-9 12527207 - Gene. 2003 Jan 2;302(1-2):165-70 8910505 - J Biol Chem. 1996 Nov 8;271(45):28697-702 16407978 - EMBO J. 2006 Jan 25;25(2):367-76 12188178 - Biotechniques. 2002 Aug;33(2):288, 290, 292 passim 12239347 - Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12847-52 12724314 - J Biol Chem. 2003 Jul 11;278(28):25568-76 2659436 - Genetics. 1989 May;122(1):19-27 16171778 - Biochem Biophys Res Commun. 2005 Nov 11;337(1):133-7 15937340 - J Biol Chem. 2005 Jul 22;280(29):26729-34 16330544 - J Biol Chem. 2006 Feb 3;281(5):2989-98 14739935 - EMBO J. 2004 Feb 11;23(3):511-9 15837196 - Structure. 2005 Apr;13(4):579-90 7791797 - Mol Cell Biol. 1995 Jul;15(7):3917-25 15916966 - Mol Cell. 2005 May 27;18(5):601-7 7688470 - Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7074-8 2234079 - Nature. 1990 Nov 8;348(6297):166-8 10090774 - Biochemistry. 1999 Mar 23;38(12):3837-49 11929951 - J Natl Cancer Inst. 2002 Apr 3;94(7):504-13 16497729 - Mol Endocrinol. 2006 Jul;20(7):1479-93 8078881 - Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8324-8 12208741 - Cancer Res. 2002 Sep 1;62(17):4916-21 16087666 - J Biol Chem. 2005 Oct 7;280(40):33792-9 16625188 - Nature. 2006 Apr 20;440(7087):1013-7 1383216 - J Biol Chem. 1992 Oct 15;267(29):21044-51 16144943 - Clin Cancer Res. 2005 Sep 1;11(17):6382-9 2199781 - Methods Enzymol. 1990;185:234-79 12941844 - Cancer Res. 2003 Aug 15;63(16):5126-35 9334185 - J Biol Chem. 1997 Oct 17;272(42):26179-87 9802897 - Mol Biol Cell. 1998 Nov;9(11):3071-83 16385472 - Med Res Rev. 2006 May;26(3):310-38 8816440 - Mol Cell Biol. 1996 Oct;16(10):5276-87 15581363 - Biochemistry. 2004 Dec 14;43(49):15510-9 |
References_xml | – volume: 16 start-page: 5276 year: 1996 end-page: 5287 ident: bib31 article-title: A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor publication-title: Mol. Cell. Biol. – volume: 122 start-page: 19 year: 1989 end-page: 27 ident: bib30 article-title: A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae publication-title: Genetics – volume: 1 start-page: 937 year: 2002 end-page: 941 ident: bib6 article-title: Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity publication-title: Mol. Cancer Ther. – volume: 440 start-page: 1013 year: 2006 end-page: 1017 ident: bib1 article-title: Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex publication-title: Nature – volume: 90 start-page: 7074 year: 1993 end-page: 7078 ident: bib35 article-title: Heat-shock protein hsp90 governs the activity of pp60v-src kinase publication-title: Proc. Natl. Acad. Sci. USA – volume: 280 start-page: 33792 year: 2005 end-page: 33799 ident: bib20 article-title: Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone publication-title: J. Biol. Chem. – volume: 272 start-page: 26179 year: 1997 end-page: 26187 ident: bib22 article-title: Domain structures and immunogenic regions of the 90-kDa heat-shock protein (HSP90). Probing with a library of anti-HSP90 monoclonal antibodies and limited proteolysis publication-title: J. Biol. Chem. – volume: 185 start-page: 234 year: 1990 end-page: 279 ident: bib27 article-title: Propagation and expression of cloned genes in yeast: 2-microns circle-based vectors publication-title: Methods Enzymol. – volume: 62 start-page: 4916 year: 2002 end-page: 4921 ident: bib9 article-title: FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases publication-title: Cancer Res. – volume: 99 start-page: 12847 year: 2002 end-page: 12852 ident: bib36 article-title: Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu publication-title: Proc. Natl. Acad. Sci. USA – volume: 280 start-page: 26729 year: 2005 end-page: 26734 ident: bib3 article-title: Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors publication-title: J. Biol. Chem. – volume: 63 start-page: 5126 year: 2003 end-page: 5135 ident: bib23 article-title: Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells publication-title: Cancer Res. – volume: 43 start-page: 15510 year: 2004 end-page: 15519 ident: bib24 article-title: Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex publication-title: Biochemistry – volume: 97 start-page: 10832 year: 2000 end-page: 10837 ident: bib29 article-title: Modulation of Akt kinase activity by binding to Hsp90 publication-title: Proc. Natl. Acad. Sci. USA – volume: 94 start-page: 504 year: 2002 end-page: 513 ident: bib37 article-title: Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228 publication-title: J. Natl. Cancer Inst. – volume: 26 start-page: 310 year: 2006 end-page: 338 ident: bib5 article-title: Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation publication-title: Med. Res. Rev. – volume: 13 start-page: 579 year: 2005 end-page: 590 ident: bib11 article-title: Structures of the N-terminal and middle domains of E. coli Hsp90 and conformation changes upon ADP binding publication-title: Structure – volume: 270 start-page: 28654 year: 1995 end-page: 28659 ident: bib19 article-title: Possible role for serine/threonine phosphorylation in the regulation of the heteroprotein complex between the hsp90 stress protein and the pp60v-src tyrosine kinase publication-title: J. Biol. Chem. – volume: 348 start-page: 166 year: 1990 end-page: 168 ident: bib25 article-title: Reduced levels of hsp90 compromise steroid receptor action in vivo publication-title: Nature – volume: 20 start-page: 1479 year: 2006 end-page: 1493 ident: bib13 article-title: Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the DNA binding and transactivation activities of the receptor publication-title: Mol. Endocrinol. – volume: 25 start-page: 367 year: 2006 end-page: 376 ident: bib32 article-title: The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90 publication-title: EMBO J. – volume: 278 start-page: 25568 year: 2003 end-page: 25576 ident: bib33 article-title: Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305 publication-title: J. Biol. Chem. – volume: 9 start-page: 3071 year: 1998 end-page: 3083 ident: bib16 article-title: Hsp90 is required for pheromone signaling in yeast publication-title: Mol. Biol. Cell – volume: 267 start-page: 21044 year: 1992 end-page: 21051 ident: bib28 article-title: Comparison of src-family cDNAs reveals distinct mechanisms underlying focus formation in transfected fibroblasts publication-title: J. Biol. Chem. – volume: 276 start-page: 32822 year: 2001 end-page: 32827 ident: bib38 article-title: Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein publication-title: J. Biol. Chem. – volume: 23 start-page: 511 year: 2004 end-page: 519 ident: bib18 article-title: Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery publication-title: EMBO J. – volume: 302 start-page: 165 year: 2003 end-page: 170 ident: bib26 article-title: Yeast is selectively hypersensitised to heat shock protein 90 (Hsp90)-targetting drugs with heterologous expression of the human Hsp90beta, a property that can be exploited in screens for new Hsp90 chaperone inhibitors publication-title: Gene – volume: 15 start-page: 3917 year: 1995 end-page: 3925 ident: bib21 article-title: Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase publication-title: Mol. Cell. Biol. – volume: 91 start-page: 8324 year: 1994 end-page: 8328 ident: bib34 article-title: Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation publication-title: Proc. Natl. Acad. Sci. USA – volume: 337 start-page: 133 year: 2005 end-page: 137 ident: bib17 article-title: A yeast-based assay reveals a functional defect of the Q488H polymorphism in human Hsp90alpha publication-title: Biochem. Biophys. Res. Commun. – volume: 18 start-page: 601 year: 2005 end-page: 607 ident: bib15 article-title: HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor publication-title: Mol. Cell – volume: 38 start-page: 3837 year: 1999 end-page: 3849 ident: bib10 article-title: Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates publication-title: Biochemistry – volume: 97 start-page: 12524 year: 2000 end-page: 12529 ident: bib7 article-title: Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90 publication-title: Proc. Natl. Acad. Sci. USA – volume: 11 start-page: 6382 year: 2005 end-page: 6389 ident: bib4 article-title: Activity of suberoylanilide hydroxamic acid against human breast cancer cells with amplification of her-2 publication-title: Clin. Cancer Res. – volume: 281 start-page: 2989 year: 2006 end-page: 2998 ident: bib2 article-title: Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones publication-title: J. Biol. Chem. – volume: 277 start-page: 29936 year: 2002 end-page: 29944 ident: bib12 article-title: Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway publication-title: J. Biol. Chem. – volume: 18 start-page: 601 year: 2005 ident: 10.1016/j.molcel.2006.12.008_bib15 article-title: HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor publication-title: Mol. Cell doi: 10.1016/j.molcel.2005.04.021 – volume: 267 start-page: 21044 year: 1992 ident: 10.1016/j.molcel.2006.12.008_bib28 article-title: Comparison of src-family cDNAs reveals distinct mechanisms underlying focus formation in transfected fibroblasts publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)36795-X – volume: 302 start-page: 165 year: 2003 ident: 10.1016/j.molcel.2006.12.008_bib26 article-title: Yeast is selectively hypersensitised to heat shock protein 90 (Hsp90)-targetting drugs with heterologous expression of the human Hsp90beta, a property that can be exploited in screens for new Hsp90 chaperone inhibitors publication-title: Gene doi: 10.1016/S0378-1119(02)01102-2 – volume: 337 start-page: 133 year: 2005 ident: 10.1016/j.molcel.2006.12.008_bib17 article-title: A yeast-based assay reveals a functional defect of the Q488H polymorphism in human Hsp90alpha publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.09.025 – volume: 272 start-page: 26179 year: 1997 ident: 10.1016/j.molcel.2006.12.008_bib22 article-title: Domain structures and immunogenic regions of the 90-kDa heat-shock protein (HSP90). Probing with a library of anti-HSP90 monoclonal antibodies and limited proteolysis publication-title: J. Biol. Chem. doi: 10.1074/jbc.272.42.26179 – volume: 440 start-page: 1013 year: 2006 ident: 10.1016/j.molcel.2006.12.008_bib1 article-title: Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex publication-title: Nature doi: 10.1038/nature04716 – volume: 9 start-page: 3071 year: 1998 ident: 10.1016/j.molcel.2006.12.008_bib16 article-title: Hsp90 is required for pheromone signaling in yeast publication-title: Mol. Biol. Cell doi: 10.1091/mbc.9.11.3071 – volume: 276 start-page: 32822 year: 2001 ident: 10.1016/j.molcel.2006.12.008_bib38 article-title: Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein publication-title: J. Biol. Chem. doi: 10.1074/jbc.M105562200 – volume: 281 start-page: 2989 year: 2006 ident: 10.1016/j.molcel.2006.12.008_bib2 article-title: Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones publication-title: J. Biol. Chem. doi: 10.1074/jbc.M508687200 – volume: 11 start-page: 6382 year: 2005 ident: 10.1016/j.molcel.2006.12.008_bib4 article-title: Activity of suberoylanilide hydroxamic acid against human breast cancer cells with amplification of her-2 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-05-0344 – volume: 97 start-page: 12524 year: 2000 ident: 10.1016/j.molcel.2006.12.008_bib7 article-title: Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.220430297 – volume: 97 start-page: 10832 year: 2000 ident: 10.1016/j.molcel.2006.12.008_bib29 article-title: Modulation of Akt kinase activity by binding to Hsp90 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.170276797 – volume: 280 start-page: 26729 year: 2005 ident: 10.1016/j.molcel.2006.12.008_bib3 article-title: Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors publication-title: J. Biol. Chem. doi: 10.1074/jbc.C500186200 – volume: 13 start-page: 579 year: 2005 ident: 10.1016/j.molcel.2006.12.008_bib11 article-title: Structures of the N-terminal and middle domains of E. coli Hsp90 and conformation changes upon ADP binding publication-title: Structure doi: 10.1016/j.str.2004.12.018 – volume: 348 start-page: 166 year: 1990 ident: 10.1016/j.molcel.2006.12.008_bib25 article-title: Reduced levels of hsp90 compromise steroid receptor action in vivo publication-title: Nature doi: 10.1038/348166a0 – volume: 122 start-page: 19 year: 1989 ident: 10.1016/j.molcel.2006.12.008_bib30 article-title: A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae publication-title: Genetics doi: 10.1093/genetics/122.1.19 – volume: 278 start-page: 25568 year: 2003 ident: 10.1016/j.molcel.2006.12.008_bib33 article-title: Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M212574200 – volume: 94 start-page: 504 year: 2002 ident: 10.1016/j.molcel.2006.12.008_bib37 article-title: Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/94.7.504 – volume: 23 start-page: 511 year: 2004 ident: 10.1016/j.molcel.2006.12.008_bib18 article-title: Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery publication-title: EMBO J. doi: 10.1038/sj.emboj.7600060 – volume: 270 start-page: 28654 year: 1995 ident: 10.1016/j.molcel.2006.12.008_bib19 article-title: Possible role for serine/threonine phosphorylation in the regulation of the heteroprotein complex between the hsp90 stress protein and the pp60v-src tyrosine kinase publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.48.28654 – volume: 280 start-page: 33792 year: 2005 ident: 10.1016/j.molcel.2006.12.008_bib20 article-title: Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone publication-title: J. Biol. Chem. doi: 10.1074/jbc.M506997200 – volume: 20 start-page: 1479 year: 2006 ident: 10.1016/j.molcel.2006.12.008_bib13 article-title: Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the DNA binding and transactivation activities of the receptor publication-title: Mol. Endocrinol. doi: 10.1210/me.2005-0531 – volume: 99 start-page: 12847 year: 2002 ident: 10.1016/j.molcel.2006.12.008_bib36 article-title: Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.202365899 – volume: 90 start-page: 7074 year: 1993 ident: 10.1016/j.molcel.2006.12.008_bib35 article-title: Heat-shock protein hsp90 governs the activity of pp60v-src kinase publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.90.15.7074 – volume: 15 start-page: 3917 year: 1995 ident: 10.1016/j.molcel.2006.12.008_bib21 article-title: Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.15.7.3917 – volume: 62 start-page: 4916 year: 2002 ident: 10.1016/j.molcel.2006.12.008_bib9 article-title: FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases publication-title: Cancer Res. – volume: 43 start-page: 15510 year: 2004 ident: 10.1016/j.molcel.2006.12.008_bib24 article-title: Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex publication-title: Biochemistry doi: 10.1021/bi048736m – volume: 185 start-page: 234 year: 1990 ident: 10.1016/j.molcel.2006.12.008_bib27 article-title: Propagation and expression of cloned genes in yeast: 2-microns circle-based vectors publication-title: Methods Enzymol. doi: 10.1016/0076-6879(90)85024-I – volume: 1 start-page: 937 year: 2002 ident: 10.1016/j.molcel.2006.12.008_bib6 article-title: Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity publication-title: Mol. Cancer Ther. – volume: 16 start-page: 5276 year: 1996 ident: 10.1016/j.molcel.2006.12.008_bib31 article-title: A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.16.10.5276 – volume: 91 start-page: 8324 year: 1994 ident: 10.1016/j.molcel.2006.12.008_bib34 article-title: Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.91.18.8324 – volume: 38 start-page: 3837 year: 1999 ident: 10.1016/j.molcel.2006.12.008_bib10 article-title: Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates publication-title: Biochemistry doi: 10.1021/bi983027s – volume: 277 start-page: 29936 year: 2002 ident: 10.1016/j.molcel.2006.12.008_bib12 article-title: Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway publication-title: J. Biol. Chem. doi: 10.1074/jbc.M204733200 – volume: 63 start-page: 5126 year: 2003 ident: 10.1016/j.molcel.2006.12.008_bib23 article-title: Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells publication-title: Cancer Res. – volume: 25 start-page: 367 year: 2006 ident: 10.1016/j.molcel.2006.12.008_bib32 article-title: The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90 publication-title: EMBO J. doi: 10.1038/sj.emboj.7600930 – volume: 26 start-page: 310 year: 2006 ident: 10.1016/j.molcel.2006.12.008_bib5 article-title: Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation publication-title: Med. Res. Rev. doi: 10.1002/med.20052 – reference: 15916966 - Mol Cell. 2005 May 27;18(5):601-7 – reference: 16385472 - Med Res Rev. 2006 May;26(3):310-38 – reference: 10090774 - Biochemistry. 1999 Mar 23;38(12):3837-49 – reference: 15581363 - Biochemistry. 2004 Dec 14;43(49):15510-9 – reference: 7499384 - J Biol Chem. 1995 Dec 1;270(48):28654-9 – reference: 11929951 - J Natl Cancer Inst. 2002 Apr 3;94(7):504-13 – reference: 15937340 - J Biol Chem. 2005 Jul 22;280(29):26729-34 – reference: 8078881 - Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8324-8 – reference: 12941844 - Cancer Res. 2003 Aug 15;63(16):5126-35 – reference: 12527207 - Gene. 2003 Jan 2;302(1-2):165-70 – reference: 1383216 - J Biol Chem. 1992 Oct 15;267(29):21044-51 – reference: 16625188 - Nature. 2006 Apr 20;440(7087):1013-7 – reference: 12208741 - Cancer Res. 2002 Sep 1;62(17):4916-21 – reference: 11050175 - Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12524-9 – reference: 16330544 - J Biol Chem. 2006 Feb 3;281(5):2989-98 – reference: 16144943 - Clin Cancer Res. 2005 Sep 1;11(17):6382-9 – reference: 15837196 - Structure. 2005 Apr;13(4):579-90 – reference: 11438552 - J Biol Chem. 2001 Aug 31;276(35):32822-7 – reference: 12239347 - Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12847-52 – reference: 16087666 - J Biol Chem. 2005 Oct 7;280(40):33792-9 – reference: 2199781 - Methods Enzymol. 1990;185:234-79 – reference: 7791797 - Mol Cell Biol. 1995 Jul;15(7):3917-25 – reference: 16407978 - EMBO J. 2006 Jan 25;25(2):367-76 – reference: 14739935 - EMBO J. 2004 Feb 11;23(3):511-9 – reference: 2659436 - Genetics. 1989 May;122(1):19-27 – reference: 2234079 - Nature. 1990 Nov 8;348(6297):166-8 – reference: 16497729 - Mol Endocrinol. 2006 Jul;20(7):1479-93 – reference: 12724314 - J Biol Chem. 2003 Jul 11;278(28):25568-76 – reference: 8816440 - Mol Cell Biol. 1996 Oct;16(10):5276-87 – reference: 9802897 - Mol Biol Cell. 1998 Nov;9(11):3071-83 – reference: 10995457 - Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10832-7 – reference: 12052835 - J Biol Chem. 2002 Aug 16;277(33):29936-44 – reference: 9334185 - J Biol Chem. 1997 Oct 17;272(42):26179-87 – reference: 7688470 - Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7074-8 – reference: 12188178 - Biotechniques. 2002 Aug;33(2):288, 290, 292 passim – reference: 16171778 - Biochem Biophys Res Commun. 2005 Nov 11;337(1):133-7 – reference: 8910505 - J Biol Chem. 1996 Nov 8;271(45):28697-702 – reference: 12481415 - Mol Cancer Ther. 2002 Sep;1(11):937-41 |
SSID | ssj0014589 |
Score | 2.4077363 |
Snippet | Heat-shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of... Heat shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 151 |
SubjectTerms | Acetylation Amino Acid Sequence Animals Cercopithecus aethiops Checkpoint Kinase 1 COS Cells HSP90 Heat-Shock Proteins - chemistry HSP90 Heat-Shock Proteins - metabolism Humans Lysine - metabolism Mice Molecular Sequence Data Mutant Proteins - chemistry Mutant Proteins - metabolism Mutation - genetics NIH 3T3 Cells Protein Binding Protein Kinases - metabolism Protein Structure, Tertiary PROTEINS Saccharomyces cerevisiae - cytology |
Title | An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function |
URI | https://dx.doi.org/10.1016/j.molcel.2006.12.008 https://www.ncbi.nlm.nih.gov/pubmed/17218278 https://www.proquest.com/docview/68420349 https://pubmed.ncbi.nlm.nih.gov/PMC1839984 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDI4QEhIXxJvxzIFrtK7NkvQ4HtOEtB14SLtFbR5iCNqJjQP_HrtpBwMkJK6to0R2Yjux_ZmQcx8hyJrJmIS7F-PSK5bHyjGbp7mxCvFcsN55OBKDB34z7o5XyGVTC4NplbXuDzq90tb1l3bNzfZ0MmnfYew0lgIR8iIFtxrQwwlXVRHf-GIRSeDdqg0eEjOkbsrnqhyvl_LZuBCAqB4Fscnk7-bpp_v5PYvyi1nqb5KN2p-kvbDkLbLiim2yFjpMvu-QUa-gPePm7yHljd6Bh0knBQW3jw6rtwl6Vb5k8KX0dDCbphG9Dd3p3YxibYJ7LQtH-2D9cPwueehf318OWN1CgZluLOfMJ1lmZeIREkZZA6cVNFTOEchNgWfhcwwLCsPjKPNJ5DNhLDpYGO3zMcg32SOrBcxzQGgntdxlSlog46kXcLMVnkcuNsJaJWyLJA3ntKnxxbHNxbNuEsmedOA3tr4UuhNr4HeLsMWoacDX-INeNkLRS_tEgwn4Y-RZI0MNRwjjIlnhyreZxlAkwvS0yH6Q6OdKJALcS5x1SdYLAgTnXv5TTB4rkG70PFPFD_-93iOyHt6RO6wTH5PV-eubOwEHaJ6fovnpnlb7_ANYfwTC |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa6DsN2Gbp32m3VYVchjq1I8jFrF6Rbk8PaArkJth5ohtYOmvTQf1_SsrNlHVBgV5uCBFISP4nUR4AvISGSNVtwhWcvLlTQvEy1567MS-s08bnQe-fpTE4uxPf5cL4DR91bGEqrbPf-uKc3u3X7pd9qs79cLPpnFDtNlSSGvETjqeYJPEU0oKh-w8n86yaUIIZNHTyS5iTevZ9rkryu6yvrYwSiuRWkKpP_9k8P8effaZR_-KXxHrxsASUbxTG_gh1fvYZnscTk3RuYjSo2sn59F3Pe2BlCTLaoGOI-Nm0uJ9hxfV3glzqwyWqZJ-xnLE_vV4weJ_ibuvJsjO6P2r-Fi_G386MJb2socDtM1ZqHrCicygJxwmhncbniFlUKYnLTCC1CSXFBaUWaFCFLQiGtI4RF4b6QooGzd7BbYT8fgA1yJ3yhlUMxkQeJR1sZROJTK53T0vUg6zRnbEswTnUurkyXSfbLRH1T7UtpBqlBffeAb1otI8HGI_KqM4rZmigGfcAjLQ87GxpcQxQYKSpf364MxSKJp6cH76NFf49EEcO9ol63bL0RIHbu7T_V4rJh6SbomWux_9_jPYTnk_PpqTk9mf04gBfxUnnAB-lH2F3f3PpPiIbW5edmtt8DT4gG-w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Acetylation+Site+in+the+Middle+Domain+of+Hsp90+Regulates+Chaperone+Function&rft.jtitle=Molecular+cell&rft.au=Scroggins%2C+Bradley+T.&rft.au=Robzyk%2C+Kenneth&rft.au=Wang%2C+Dongxia&rft.au=Marcu%2C+Monica+G.&rft.date=2007-01-12&rft.issn=1097-2765&rft.volume=25&rft.issue=1&rft.spage=151&rft.epage=159&rft_id=info:doi/10.1016%2Fj.molcel.2006.12.008&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_molcel_2006_12_008 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1097-2765&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1097-2765&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1097-2765&client=summon |